AJGP
HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Geriatr Psychiatry 15:84-87, January 2007
© 2007 American Association for Geriatric Psychiatry
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a Colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mendez, M. F.
Right arrow Articles by Licht, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mendez, M. F.
Right arrow Articles by Licht, E.

Brief Report

Preliminary Findings: Behavioral Worsening on Donepezil in Patients With Frontotemporal Dementia

Mario F. Mendez, M.D., Ph.D., Jill S. Shapira, R.N., Ph.D., Aaron McMurtray, M.D., and Eliot Licht, M.D.

From the Department of Neurology, University of California at Los Angeles, Los Angeles, CA.

Objective: The objective of this study was to evaluate donepezil, an acetylcholinesterase inhibitor, in the treatment of frontotemporal dementia (FTD).

Methods: Twelve patients with FTD who received donepezil for six months were compared with 12 FTD controls on behavioral measures.

Results: The groups did not differ on most variables at baseline or at six months; however, the donepezil group had greater worsening on the FTD Inventory. Four treated patients had increased disinhibited or compulsive acts, which abated with discontinuation of the medication.

Conclusion: There were no changes in global cognitive performance or dementia severity; however, a subgroup of patients with FTD can experience worsening of symptoms with donepezil.

Key Words: Frontotemporal dementia • donepezil • acetylcholinesterase inhibitors




This article has been cited by other articles:


Home page
AM J ALZHEIMERS DIS OTHER DEMENHome page
L. Massimo and M. Grossman
Patient Care and Management of Frontotemporal Lobar Degeneration
American Journal of Alzheimer's Disease and Other Dementias, May 1, 2008; 23(2): 125 - 131.
[Abstract] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
M. F. Mendez, E. C. Lauterbach, S. M. Sampson, and ANPA Committee on Research
An Evidence-Based Review of the Psychopathology of Frontotemporal Dementia: A Report of the ANPA Committee on Research
J Neuropsychiatry Clin Neurosci, May 1, 2008; 20(2): 130 - 149.
[Abstract] [Full Text] [PDF]


Home page
AM J ALZHEIMERS DIS OTHER DEMENHome page
R. J. Caselli and R. Yaari
Medical Management of Frontotemporal Dementia
American Journal of Alzheimer's Disease and Other Dementias, January 1, 2008; 22(6): 489 - 498.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
Copyright © 2007 American Association for Geriatric Psychiatry